Pfizer is investing in mRNA technology—to help prevent, cure and treat disease. Collaborations with @BioNTech_Group @BeamTx @AcuitasTx and @Codex_dna expand our capabilities to pioneer even more innovative therapies and vaccines. #JPM22

— Albert Bourla (@AlbertBourla) January 10, 2022